Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.24
BATS BZX Real-Time Price
As of 10:35am ET
 -0.16 / -0.92%
Today’s Change
8.31
Today|||52-Week Range
24.43
-17.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line629.0M-41.7M1.4B477.8M
 
 
 
 
 
Depreciation674.0M656.4M799.9M787.7M
 
 
 
 
 
Total Other Cash Flow-25.0M-144.7M229.2M410.1M
 
 
 
 
 
Funds From Operations324.0M226.6M497.3M316.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-592.0M-31.1M-77.0M-161.7M
 
 
 
 
 
Net Cash Flow - Operating Activities916.0M257.7M574.3M477.9M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-992.1K-3.2M-3.0M
 
 
 
 
Decrease In Investments0.00992.1K1.1M-47.6K
 
 
 
 
Capital Expenditures-38.0M-36.4M-48.9M-47.7M
 
 
 
 
 
Fixed Asset Disposal1.3B810.1M1.1B121.2M
 
 
 
 
 
Net Assets From Acquisitions -9.0M9.0M0.000.00
 
 
 
Other Investing - Uses0.000.000.00-25.5M
 
 
Net Cash Flow Investing1.1B773.8M1.0B25.4M
 
 
 
 
 
 
FinancingShort Term Borrowings-1.0M-5.9M-1.4M1.4M
 
 
 
 
 
Long Term Borrowings6.2B-51.1M327.2M2.9B
 
 
 
 
 
Long Term Debt Reduction-7.6B-158.3M-1.9B-4.5B
 
 
 
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing----------
Other Uses - Financing9.0M28.7M20.8M9.9M
 
 
 
 
 
Net Cash Flow - Financing-1.4B-244.0M-1.6B-1.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash8.0M15.8M16.9M1.1M
 
 
 
 
 
 
Net Change In Cash660.0M787.5M2.7M-1.2B